1-(6-(Azepan-1-yl)-2-methylpyridin-3-yl)propan-1-one

Catalog No.: 
ACSKLJ122
CAS No.: 
1355214-70-8
Molecular Formula: 
C15H22N2O
Molecular Weight: 
246.35
1-(6-(Azepan-1-yl)-2-methylpyridin-3-yl)propan-1-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$206.00InquiryInquiry
250mg97%$379.00InquiryInquiry
1g97%$1106.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(6-(Azepan-1-yl)-2-methylpyridin-3-yl)propan-1-one
IUPAC Name1-(6-(azepan-1-yl)-2-methylpyridin-3-yl)propan-1-one
Molecular FormulaC15H22N2O
Molecular Weight246.35
SMILESCCC(C1=CC=C(N2CCCCCC2)N=C1C)=O
InChI KeyDELXDGFBUAPODG-UHFFFAOYSA-N
Synonym1-(6-Azepan-1-yl-2-methyl-pyridin-3-yl)-propan-1-one;1-Propanone, 1-[6-(hexahydro-1H-azepin-1-yl)-2-methyl-3-pyridinyl]-
CAS No.1355214-70-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACSKLJ122 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSKLJ122 route product structure diagram
    ACSKLJ1221355214-70-8
Inquiry

2. ACSKLJ122 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSKLJ122 route product structure diagram
    ACSKLJ1221355214-70-8
Inquiry

3. ACSKLJ122 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSKLJ122 route product structure diagram
    ACSKLJ1221355214-70-8
Inquiry

Comments (0)